王玲

王玲 is a declared insider of 奥精医疗 (chief executive), with filings sourced from SSE / SZSE (CSRC). Between 29 April 2025 and 31 December 2025, the trades on record add up to 4 filings.

In open-market terms, that means 1 purchase worth €140k on one side and 3 sales worth €23k on the other. Netting one side against the other leaves €117k of net buying. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.

The record was last updated on 31 December 2025 with an open-market sale (€12k) in 奥精医疗. The last insider purchase was made public on 29 April 2025, 559 days ago. Publication is fast: at least half of the trades appear on SSE / SZSE (CSRC) on the same day. Until a filing is published, the market cannot know about the trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SSE / SZSE (CSRC). They describe what insiders did and are not a recommendation.